Aberrant activation of the Jak/Stat pathway has, for example, been shown to induce expression of the immunoregulatory cytokines IL-10 and transforming growth factor beta (TGF-β) in malignant CTCL cells [68, 108]. The gene discussed is IL10; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.